Mandate

Vinge advises on the sale of Fiomi Diagnostics AB

March 05, 2012

Vinge has advised the shareholders of Fiomi Diagnostics AB in connection with the sale of the shares in the company to Trinity Biotech plc, which is quoted on NASDAQ. Fiomi, which is based in Uppsala, develops platforms for point-of-care diagnostics based on a technology which originated from Uppsala Åmice AB.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Claes Henriksson and Louise Markgren as well as project assistants Ida Norlin

Related

Vinge has advised Skeptiva AB in connection with its financing round

Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026

Vinge represents Studsvik AB (publ) in the acquisition of Kärnfull Next AB

Vinge has represented Studsvik AB (publ) in connection with the acquisition of Kärnfull Next AB, a company developing methods for building small modular nuclear reactors.
March 10, 2026